U.S. market Closed. Opens in 17 hours 20 minutes

CRDF | Cardiff Oncology, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-31
Revenue488.00K386.00K359.00K365.99K245.00K378.00K505.40K381.07K312.81K280.18K259.25K450.40K257.70K265.67K650.00K
Cost of Revenue398.00K200.00K500.00K11.23M11.16M597.00K1.81M1.73M629.19K15.44KN/AN/AN/AN/AN/A
Gross Profit90.00K186.00K-141.00K-10.87M-10.92M-219.00K-1.31M-1.35M-316.38K264.74K259.25KN/A257.70K265.67KN/A
Operating Expenses45.50M40.29M29.21M19.45M16.92M16.17M22.12M38.01M24.96M15.21M10.95M5.30M3.23M5.64M3.05M
Selling, General & Admin12.64M13.18M11.84M8.22M5.76M8.01M14.23M23.00M14.36M8.54M7.00M3.38M2.32M1.95M2.22M
Research & Development32.86M27.11M17.38M11.24M11.16M8.16M7.88M15.01M10.59M6.66M3.95M1.92M910.68K3.69MN/A
Other Operating Expenses-98.00K-383.00K15.00K-28.24K2.00K-237.00KN/AN/AN/AN/AN/AN/AN/AN/A830.00K
Operating Income-45.41M-39.90M-28.86M-19.09M-16.68M-17.05M-25.60M-39.36M-25.27M-14.95M-10.69M-4.85M-2.98M-5.38M-2.39M
Other Expenses / Income3.97M1.20M564.00K-220.80K264.00K-266.00K689.05K151.45K-2.20M619.67K-1.12M-6.72M794.06K45.55K-90.00K
Before Tax Income-41.44M-38.70M-28.29M-19.31M-16.41M-16.46M-24.91M-39.20M-27.47M-14.33M-11.81M-11.57MN/AN/A-2.48M
Income Tax Expenses230.10K-1.20M-549.00K-26.73K-262.00K617.64KN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-41.44M-37.51M-27.74M-19.28M-16.15M-16.46M-24.91M-39.20M-27.47M-14.33M-11.81M-11.57M-2.24M-5.45M-2.48M
Interest ExpensesN/A1.58MN/A1.52KN/A25.41K1.03MN/A1.53M843.26K17.00KN/A56.64K115.58K-90.00K
Basic Shares Outstanding44.68M43.60M39.03M20.87M5.97M2.33M481.67K419.10K363.92K262.56K235.81K181.49K134.88K99.43K70.00K
Diluted Shares Outstanding44.68M43.60M39.03M20.87M5.97M2.33M481.67K420.57K367.39K264.87K235.81K181.49K134.88K99.43K70.00K
EBITDA-45.01M-39.67M-28.69M-18.56M-16.21M-15.50M-22.63M-38.13M-25.57M-13.25M-11.66M-11.53M-2.17M-5.33M-2.52M
EBITDA Margin-9,224.18%-10,276.17%-7,991.36%-5,070.67%-6,617.14%-4,100.79%-4,476.66%-10,007.08%-8,173.25%-4,728.21%-4,498.98%-2,559.51%-842.97%-2,004.47%-387.69%
EBIT-41.21M-37.12M-28.29M-19.31M-16.41M-15.82M-23.87M-39.20M-25.95M-13.48M-11.79M-11.57M-2.18M-5.33M-2.57M
EBIT Margin-8,444.86%-9,617.36%-7,880.50%-5,274.73%-6,699.59%-4,184.64%-4,723.51%-10,287.75%-8,294.31%-4,812.02%-4,549.32%-2,567.91%-846.96%-2,007.62%-395.38%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙